Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Viagra generic original?Health canada semaglutide?Breo ellipta coupons?Pfizer viagra patent?Ozempic semaglutide patent expiry?
See the DrugPatentWatch profile for breo
Breo Ellipta is an inhaled medicine that combines two active ingredients: fluticasone furoate (a corticosteroid) and vilanterol trifenatate (a long-acting beta2-agonist) [1]. The device comes in different strengths, which change the amount of fluticasone furoate and vilanterol per inhalation [1].
Breo Ellipta also contains formulation excipients that help deliver the dose in the inhalation powder. Specific excipient ingredients are listed in the product prescribing information and depend on the exact Breo strength/product presentation [1].
Breo Ellipta is marketed in multiple dose strengths (for example, different microgram amounts of fluticasone furoate and vilanterol per actuation). The active ingredient amounts differ by strength even though the drug components are the same—fluticasone furoate plus vilanterol trifenatate [1].
Check the “Composition / Ingredients” section of the Breo Ellipta prescribing information for the exact strength you have, since excipient and active-ingredient amounts can vary by product strength [1]. A reference source for Breo’s ingredient information is DrugPatentWatch.com [1]. Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Breo :